Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Introdution: Immune checkpoint inhibitors (ICIs) have significantly improved clinical outcomes for a wide range of cancers but can also lead to serious or fatal immune-related adverse events (irAEs). Although ICI-related pericardial toxicities have been reported, the clinical features are not well c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhuo, Pei, Jie, Sun, Ximu, Liu, Lihong, Lu, Wenchao, Guo, Qixiang, Lyu, Jiayou, Liu, Yuwei, Zhang, Yuhui, Zhao, Zhixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283181/
https://www.ncbi.nlm.nih.gov/pubmed/34276364
http://dx.doi.org/10.3389/fphar.2021.663088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283181/
https://www.ncbi.nlm.nih.gov/pubmed/34276364
http://dx.doi.org/10.3389/fphar.2021.663088

Ejemplares similares